PNC Financial Services Group
CGEM icon

PNC Financial Services Group’s Cullinan Oncology CGEM Stock Holding History

PNC Financial Services Group’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273 Sell
15
-3
-17% -$45 ﹤0.01% 5072
2026
Q1 		$256 Buy
18
+13
+260% +$167 ﹤0.01% 5009
2025
Q4 		$52 Sell
5
-225
-98% -$2.03K ﹤0.01% 5101
2025
Q3 		$1.36K Buy
230
+156
+211% +$1.14K ﹤0.01% 4606
2025
Q2 		$557 Buy
74
+61
+469% +$490 ﹤0.01% 4664
2025
Q1 		$98 Hold
13
– – ﹤0.01% 4820
2024
Q4 		$158 Hold
13
– – ﹤0.01% 4671
2024
Q3 		$218 Hold
13
– – ﹤0.01% 4674
2024
Q2 		$227 Hold
13
– – ﹤0.01% 4647
2024
Q1 		$222 Sell
13
-4
-24% -$62 ﹤0.01% 4599
2023
Q4 		$173 Buy
17
+1
+6% +$9 ﹤0.01% 4495
2023
Q3 		$145 Sell
16
-463
-97% -$4.82K ﹤0.01% 4546
2023
Q2 		$5.15K Buy
+479
New +$5.09K ﹤0.01% 4109
2021
Q2 		– Sell
-7,356
Closed -$306K – 4192
2021
Q1 		$306K Buy
+7,356
New +$299K ﹤0.01% 1895

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

PNC Financial Services Group's CGEM Position: Q2 2026 in Review

PNC Financial Services Group reduced its Cullinan Oncology (CGEM) stake by 17% in Q2 2026, selling an estimated $45 and leaving 15 shares worth $273. The position accounts for ﹤0.01% of the portfolio, ranked #5072.

PNC Financial Services Group first reported a position in CGEM in Q1 2021 and has held it in 14 quarters since. The position peaked at $306K in Q1 2021. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • PNC Financial Services Group held 15 shares of Cullinan Oncology worth $273 as of Q2 2026.
  • PNC Financial Services Group sold 3 Cullinan Oncology shares in Q2 2026, an estimated $45.
  • Cullinan Oncology made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #5072 holding.
  • PNC Financial Services Group first reported a position in Cullinan Oncology in Q1 2021 and has held it in 14 quarters since.
  • PNC Financial Services Group's Cullinan Oncology position peaked at $306K in Q1 2021.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.